{"transactions":[{"id":4152189,"issuer":{"id":94908,"kind":"organization","name":"Mirati Therapeutics, Inc.","symbol":"MRTX"},"owners":[{"id":162740,"kind":"organization","name":"Tuesday Thirteen Inc.","position":1,"cik":"0001723227","reported_name":"Tuesday Thirteen Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-11-22T17:02:31.000Z","date":"2017-09-21","kind":"sale","acquired":false,"shares":1000,"price":10.65,"value":10650.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These securities are owned directly by the reporting person, who may be deemed to be a member of a \"group\" for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, consisting of (i) Boxer Capital, LLC (\"Boxer Capital\"), (ii) Boxer Asset Management Inc. (\"Boxer Management\"), (iii) MVA Investors, LLC, (iv) Braslyn Ltd., (v) the reporting person, (vi) Joseph C. Lewis, (vii) Christopher Fuglesang, (viii) Rodney W. Lappe, (ix) Ivan M. Lieberburg, (x) Aaron I. Davis, (xi) Neil Reisman and (xii) Shehan B. Dissanayake. Joseph C. Lewis is the sole indirect beneficial owner of and controls Tuesday Thirteen Inc."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-17-027319","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1576263/000089924317027319/doc4.xml","form_type":"4"}}]}